B57.4

Clinical Causes: Transmission of *Trypanosoma cruzi* through insect bites, primarily from triatomine bugs ('kissing bugs') Contamination of food or beverages with infected insect feces Congenital transmission from mother to fetus Blood transfusions or organ transplants from infected donors Rarely, laboratory accidents or transmission through contaminated needles

Key Symptoms: Neurological symptoms such as numbness, weakness, or paralysis Muscle wasting or atrophy in affected regions Cognitive disturbances if the brain is involved Pain, tingling, or burning sensation in affected areas Signs of autonomic nervous system involvement, such as gastrointestinal or cardiac symptoms General fatigue and malaise

Diagnosis Path: Diagnosing Chagas' disease with nervous system involvement involves a combination of clinical assessment and laboratory tests. Blood tests, including serological assays, can identify antibodies against *Trypanosoma cruzi*. Imaging studies like MRI or CT scans may be used to evaluate neurological damage. Electrophysiological tests can assess nerve function. A comprehensive evaluation helps determine the extent of nervous system involvement and guides management.

Treatment Protocols: Treatment options focus on controlling the infection and managing neurological symptoms. Antiparasitic medications such as benznidazole or nifurtimox are used to eliminate the parasite, especially in the early stages. In cases with neurological damage, supportive therapies including physical therapy, occupational therapy, and symptomatic medications can improve quality of life. Ongoing medical monitoring is essential for detecting and treating complications.